FCGR2A and pneumocystosis: Indeed, when PCP convalescent serum was added to the AMs lacking FcγRs (compared with wild-type and Card9−/− AMs), the macrophages demonstrated significant impairment of Pneumocystis killing, indicating the importance of FcγR antibody-mediated interaction with Pneumocystis.